ArticleBMJ open2021

Open-label, randomised, clinical trial to evaluate the immunogenicity and safety of a prophylactic vaccination of healthcare providers by administration of a heterologous vaccine regimen against Ebola in the Democratic Republic of the Congo: the study protocol.

Ynke Larivière et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.